Landmark Liver Fibrosis Research Published in Cell, Cloud-Clone Aids ROCK2-Targeted Drug TDI01 Development
Breakthrough Study in Cell Paves Way for ROCK2-Targeted Therapy TDI01 in Liver Fibrosis KATY, TX / 500NewsWire / June 16, 2026 / In April 2026, a groundbreaking study—Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis—was published online in the prestigious international journal Cell. This research reveals for the first time that selective upregulation of ROCK2 in liver…
